Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report Fourth Quarter 2020

Fourth quarter 2020 Continuing operations · Order intake 22,051 million SEK · Revenues 22,408 million SEK · Operating profit 3,487 million SEK · Operating margin 15.6% · Adjusted operating profit 4,505 million SEK · Adjusted operating margin 20.1% · Profit after net financial items 3,407 million SEK · Adjusted profit after net financial items 4,424 million SEK · Profit for the period 2,633 million SEK · Earnings per share 2.10 SEK · Adjusted earnings per share 2.68 SEK · Cash flow from operations 5,228 million SEK Discontinued operations ·

Konecranes’ financial statement release 2020 will be published on February 4, 2021

KONECRANES PLC PRESS RELEASE January 21, 2021 at 09:00 EET Konecranes’ financial statement release 2020 will be published on February 4, 2021 Konecranes will publish its financial statement release 2020 on Thursday, February 4, 2021 at approximately 8:30 a.m. Finnish time. The report will be available on the company’s website at www.konecranes.com after publishing. A live international telephone conference for analysts, investors and media will be arranged on the publishing day at 10:30 a.m. EET. The event will be held in English. The financial statement release 2020 will be

Invitation to Kesko’s Q4-webcast on 3 February 2021

A stock exchange release concerning Kesko's financial results for 2020 will be published on Wednesday, 3 February 2021, at around 9.00 am (EET). A results conference, conducted in Finnish, will be held at 11.00 am (EET) as a webcast and a conference call available at www.kesko.fi/raporttikeskus. A transcript of the Q&A session will be available in English afterwards at www.kesko.fi/report-centre. An audiocast/teleconference, conducted in English, will be held at 12.30 noon (EET). A link to the audiocast/teleconference is available at www.kesko.fi/report-centre. Registration is

Gold&Green® Foods and Taco Bell cooperation expands to UK

As Veganuary hits, Taco Bell has partnered with Gold&Green Pulled Oats® to launch a brand-new range of plant-based fillings for their iconic tacos. Available from the 7th January in all 53 Taco Bell UK restaurants, the new veggie offering is perfect for those looking to go meat-free or meat-lovers looking for something new and tasty to kick start their year! Gold&Green’s Pulled Oats® has previously been on the menu of all Taco Bell restaurants in Finland and Spain. The Mexican-inspired restaurant is extending its offering to meet the growing demand for meat-less meals. Deliciously

Kiilto’s innovation programme created new business

Kiilto's strong experimental culture has generated new products: Erisan+, a natural cosmetics collection, is a fast-tracked winner of Kiilto’s internal innovation competition.The Kiilto Up idea competition was first launched among Kiilto employees in 2017, inviting them to contribute to business development. The aim was to find new kinds of products and services. Four months of frantic efforts culminated in the victory of the Microbiome team in December with the project “Flourish with skin flora!”. “We were slightly surprised by our win, since our idea still needs some refinement.

Atrium Ljungberg is hosting a presentation of Q4 Report 2020 on 9 February at 10.00 CET

Atrium Ljungberg is hosting an online broadcast of the Q4 Report 2020 presentation at 10.00 CET on 9 February 2021. The Year-End Report 2020 will be published at 7.30 CET on the same day.Equity analysts, investors, media and other stakeholders are invited to participate in the conference where CEO Annica Ånäs and CFO Martin Lindqvist will present the results for 2020. The presentation will be held in English and can be watched online using the following link: https://tv.streamfabriken.com/en-atrium-ljungberg-q4-2020 After the broadcast, the presentation and written material can be

Antibiotic resistance may spread even more easily than expected

Pathogenic bacteria in humans are developing resistance to antibiotics much faster than expected. Now, computational research at Chalmers University of Technology, Sweden, shows that one reason could be significant genetic transfer between bacteria in our ecosystems and to humans. This work has also led to new tools for resistance researchers. According to the World Health Organisation, antibiotic resistance is one of the greatest threats to global health, food safety and development. It already causes over 33,000 deaths a year in Europe alone. Completely different species

Fourth quarter 2020 trading update

Aker BP will publish its financial report for the fourth quarter 2020 on Thursday 4 February 2021. The company issues this statement to summarize its production and sales volumes and certain accounting-related topics for the quarter. Oil and gas production and sales Aker BP produced 223.1 thousand barrels of oil equivalents per day (mboepd) in the fourth quarter. The increase from the previous quarter was driven by new wells on production at Ærfugl and Alvheim, by higher production from Johan Sverdrup, and by generally lower maintenance activity. Average production for the year 2020

Nel CMD 2021: Launches 1.5 USD/kg target for green renewable hydrogen to outcompete fossil alternatives

(Oslo, 21 January 2021) Nel ASA (Nel, OSE:NEL) today hosts the Nel Capital Markets Day 2021, outlining the target of producing green hydrogen at USD 1.5 per kilo* by 2025, to outcompete fossil alternatives. Cost reductions through scale-up of production to multi-GW scale, growing the organization to add capacities and capabilities, and investing in technology for the near- and long-term are crucial components in ensuring that Nel continues to be the global leader in the hydrogen industry. "Green renewable hydrogen is set to outcompete fossil alternatives, and Nel is placed in the centre

ABS AIP for DSME’s Solid Oxide Fuel Cell Technology

AIP Follows JDP to Replace a Diesel Generator Onboard a VLCC(OKPO, Korea) ABS has granted Approval in Principle (AIP) to Solid Oxide Fuel Cell (SOFC) technology developed by Daewoo Shipbuilding & Marine Engineering Co., Ltd. (DSME). Granting of AIP follows two joint development projects between ABS and DSME, the latest to develop SOFC technology to replace at least one of three diesel generators typically on-board a Very Large Crude Carrier (VLCC). ABS is now working with DSME on future research and development areas to be carried out during detailed design and testing of the SOFC

Surgical Science has completed a directed share issue of approximately SEK 322 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.  Surgical Science Sweden AB (publ) (“Surgical Science” or the “Company”) has, based on the authorization granted by the annual general meeting held on 6 May 2020, and in accordance with what the Company announced in a press

Lundin Mining Announces 2020 Production Guidance Achieved for All Metals; Fourth Quarter and Full Year 2020 Results to be Released February 18, 2021

TORONTO, ON, January 20, 2021 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) announces production results for the three and twelve months ended December 31, 2020. The consolidated financial results for the year ended December 31, 2020 will be published on February 18, 2021. Highlights · 2020 annual production guidance achieved for all metals. Production of 230,781 t of copper was at the upper end of the guidance range and gold production of 163,000 oz exceeded guidance. · Candelaria copper and gold production both exceeded

Democratic reforms will determine how successful the US administration can be on climate

President Joe Biden takes office today. The new US president has already shown he is serious about climate. But roadblocks in Congress – and emerging threats to democracy – mean the way forward will not be easy. Stockholm Environment Institute Senior Scientist Pete Erickson, director of the SEI US Climate Policy Program, puts forward four climate policy developments  to keep an eye on in 2021.In short: Economic recovery investment to help build out a low-carbon economy Economic recovery efforts can push

Q-Free: The Board’s statement regarding the mandatory offer from Rieber & Søn AS

The enclosed statement is made by the board of directors (the "Board") of Q-Free ASA ("Q-Free") in accordance with Section 6-16 of the Norwegian Securities Trading Act in connection with the mandatory offer from Rieber & Søn AS ("Rieber & Søn") to acquire all the issued and outstanding shares in Q-Free not already owned by Rieber & Søn, against a consideration of NOK 4.70 in cash per share (the "Offer"), made in the offer document dated 14 January 2021 (the "Offer Document"). Rieber & Søn is represented on the Board of Q-Free by Trond Valvik, who holds the position as the chairman of the

Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this stock exchange announcement or the acceptance of any tender of shares would contravene applicable laws or regulations. (Oslo, 20 January 2021): Reference is made to the mandatory offer (the “Offer”) from Rieber & Søn AS (the “Offeror”) to acquire all shares in Q-Free ASA (“Q-Free” or the “Company”) pursuant to an offer document

Surgical Science announces intention to carry out a directed share issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Surgical Science Sweden AB (publ) (“Surgical Science” or the “Company”) hereby announces its intention to carry out a directed share issue corresponding to up to approximately 10 percent of the total number of outstanding

Surgical Science has entered into an agreement to acquire a company within the robotic surgery segment

Surgical Science Sweden AB (publ) ("Surgical Science" or the "Company") has entered into a conditional agreement to acquire all shares outstanding of Mimic Technologies Inc. (“Mimic”) for an initial consideration of USD 18.0 million (approximately SEK 150 million) on a cash and debt-free basis. In addition, a maximum deferred contingent consideration of USD 15.6 million (approximately SEK 130 million) tied to qualifying revenue targets for the years 2021, 2022 and 2023 may be paid. The maximum total consideration, given that all conditions are met, amounts therefore to USD 33.6 million (

Pihlajalinna Plc: Share repurchase 20.1.2021

Pihlajalinna Plc Stock Exchange Release 20.1.2021 Pihlajalinna Plc: Share repurchase 20.1.2021 In the NASDAQ OMX Helsinki Trade date           20.1.2021Bourse trade         BuyShare                  PIHLISAmount             10 000 SharesAverage price/ share    9,7581 EURTotal cost            97 581,00 EUR Company now holds a total of 51 510 sharesincluding the shares repurchased on 20.1.2021 On behalf of

Aker ASA: Successful placement of new unsecured bonds

Aker ASA has today successfully issued NOK 500 million in the bond with ISIN NO0010868979 and maturity in November 2024 (AKER15).The issue was placed at a price equivalent to an issued spread of 3 months NIBOR + 2.25%. The outstanding volume after the transaction is NOK 2.000 million and the settlement date will be 26 January 2021. The net proceeds from the transaction will be used for general corporate purposes. DNB Markets, Nordea, Pareto and SEB acted as joint lead managers for the tap issue. For further information, please contact:Christina Chappell Glenn, Head of Investor

#21-22 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-21 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Adapteo Plc - Managers' transactions - Isell Lind af Hageby

Adapteo Plc Managers’ transactions 20 January 2021 at 5:00 p.m. CET Person subject to the notification requirementName: Isell Lind af Hageby, PhilipPosition: Chief Executive OfficerIssuer: Adapteo PlcLEI: 549300PDEX0KMLMDNZ32 Notification type: INITIAL NOTIFICATIONReference number: 549300PDEX0KMLMDNZ32_20210120161751_7 ____________________________________________ Transaction date: 2021-01-19Venue not applicableInstrument type: SHAREISIN: FI4000383898Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 4040 Unit

Sedana Medical submits application for marketing approval in Switzerland

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for marketing approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care in Switzerland.“Through this application, we cover another important European market ahead of our upcoming launch. If all goes well, we expect to be able to launch in the second half of 2021 in the first 15 European countries for which we have already submitted an application. In Switzerland, we expect to be able to launch in 2022," said Christer

There are no items matching the current filter
There are no more items matching the current filter
Back to top